Fig. 1: Patient flow from screening to 12-month follow-up. | Nature Medicine

Fig. 1: Patient flow from screening to 12-month follow-up.

From: Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial

Fig. 1

From 697 on-site screenings, 502 patients were randomized (1:1) to lifestyle intervention or usual care. Three patients withdrew their consent to data use and had all their data deleted. A total of 91 patients were lost to follow-up at 6 months and another 27 patients were lost to follow-up between 6 and 12 months. All 390 patients with available HbA1c measurements at baseline and 6 months were included in the analysis of the primary endpoint (change in HbA1c at 6 months).

Back to article page